We are live on
!
Find out more
IP
Invenire Partners Portfolio holdings
AUM
$65.4M
1-Year Est. Return
18.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.15%
1 Year Est. Return
-18.1%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$65.4M
AUM Growth
-$9.91M
(-13%)
Cap. Flow
-$2.45M
Cap. Flow
% of AUM
-3.75%
Top 10 Holdings %
Top 10 Hldgs %
57.26%
Holding
36
New
7
Increased
10
Reduced
3
Closed
10
Top Buys
| 1 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$3.11M |
| 2 |
Apyx Medical
APYX
|
+$2.63M |
| 3 |
DocGo
DCGO
|
+$2.48M |
| 4 |
OptimizeRx
OPRX
|
+$2.08M |
| 5 |
NOTV
Inotiv
NOTV
|
+$1.74M |
Top Sells
| 1 |
NOA
North American Construction
NOA
|
+$3.38M |
| 2 |
Unisys
UIS
|
+$3.22M |
| 3 |
DLA
Delta Apparel Inc.
DLA
|
+$2.73M |
| 4 |
Columbus McKinnon
CMCO
|
+$1.95M |
| 5 |
SHYF
The Shyft Group
SHYF
|
+$1.92M |
Sector Composition
| 1 | Healthcare | 34.72% |
| 2 | Technology | 26.01% |
| 3 | Industrials | 21.81% |
| 4 | Communication Services | 9.23% |
| 5 | Consumer Discretionary | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Harrow
HROW
$1.74B
| $5.48M | 8.38% |
453,794
-60,000
| -12% | -$487K |
|
2
DHI Group
DHX
$177M
| $5.19M | 7.93% |
964,180
+280,078
| +41% | +$1.47M |
|
3
TETRA Technologies
TTI
$1.37B
| $4.25M | 6.5% |
1,184,400
+71,900
| +6% | +$283K |
|
|
4
Apyx Medical
APYX
$180M
| $4.25M | 6.49% |
945,711
+367,758
| +64% | +$2.63M |
|
5
InfuSystem Holdings
INFU
$180M
| $3.26M | 4.99% |
466,736
+66,233
| +17% | +$555K |
|
6
Arena Group
AREN
$47.6M
| $3.16M | 4.83% |
241,355
-145,434
| -38% | -$1.61M |
|
|
CTLP
7
DELISTED
Cantaloupe
CTLP
| $3.09M | 4.73% |
888,295
+186,599
| +27% | +$1.02M |
|
8
PAR Technology
PAR
$674M
| $2.97M | 4.54% |
100,569
+3,000
| +3% | +$111K |
|
|
EGIO
9
DELISTED
Edgio, Inc. Common Stock
EGIO
| $2.92M | 4.46% |
+26,250
| New | +$3.11M |
|
10
Marcus Corp
MCS
$708M
| $2.88M | 4.4% |
207,128
| – | – |
|
|
11
DocGo
DCGO
$64.3M
| $2.73M | 4.17% |
+275,100
| New | +$2.48M |
|
12
DNOW Inc
DNOW
$2.54B
| $2.71M | 4.14% |
269,350
| – | – |
|
|
EVRI
13
DELISTED
Everi Holdings
EVRI
| $2.51M | 3.83% |
154,500
+42,500
| +38% | +$783K |
|
14
Primoris Services
PRIM
$4.66B
| $2.36M | 3.62% |
145,500
| – | – |
|
15
Artivion
AORT
$1.22B
| $2.34M | 3.59% |
169,414
+55,000
| +48% | +$1.11M |
|
16
TTEC Holdings
TTEC
$105M
| $2.25M | 3.43% |
50,682
| – | – |
|
|
SQNS
17
Sequans Communications SA
SQNS
$43.6M
| $2.13M | 3.25% |
23,814
+772
| +3% | +$64.5K |
|
18
Clarus
CLAR
$132M
| $2.12M | 3.24% |
157,090
-20,000
| -11% | -$389K |
|
19
Identive
INVE
$67.2M
| $2.02M | 3.09% |
160,927
+41,784
| +35% | +$572K |
|
|
NOTV
20
DELISTED
Inotiv
NOTV
| $1.6M | 2.45% |
+95,000
| New | +$1.74M |
|
|
21
OptimizeRx
OPRX
$126M
| $1.56M | 2.38% |
+105,000
| New | +$2.08M |
|
22
Sensus Healthcare
SRTS
$49.7M
| $1.49M | 2.28% |
+118,867
| New | +$1.42M |
|
|
SNCR
23
DELISTED
Synchronoss Technologies
SNCR
| $1.39M | 2.13% |
135,508
| – | – |
|
|
SRXH
24
SRX Global
SRXH
$45.5M
| $700K | 1.07% |
450
| – | – |
|
|
25
PUT
Clarus
CLAR
$132M
| $58.5K | 0.09% |
+300
| New | +$5.84K |
|
Similar funds
KCIA
ACK
LDFO
SAM
BVLP
HLOC
FFM
BI
Invenire Partners's Q3 2022 Portfolio in Review
As of Q3 2022, Invenire Partners held 36 positions worth $65.4M, down 13% from $75.3M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Invenire Partners withdrew a net $2.45M in Q3 2022, closing 10 positions and reducing 3 holdings. Its most notable exit was North American Construction, an estimated $3.38M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.
Against the trend, Invenire Partners opened a new position in Edgio, Inc. Common Stock worth $2.92M.
- Invenire Partners's largest Q3 2022 buy was Edgio, Inc. Common Stock: 26,250 shares worth $2.92M.
- Invenire Partners added most to Apyx Medical in Q3 2022, an estimated $2.63M increase.
- Invenire Partners's biggest Q3 2022 reduction was Arena Group, cutting an estimated $1.61M.
- Invenire Partners fully exited North American Construction in Q3 2022, selling an estimated $3.38M.
- Invenire Partners's ten largest holdings make up 57% of its $65.4M portfolio in Q3 2022.
- Invenire Partners opened 7 new positions and closed 10 in Q3 2022.
- Invenire Partners's portfolio value fell 13% quarter-over-quarter to $65.4M.
Based on Invenire Partners's 13F filing for Q3 2022, filed 14 Nov 2022.